FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

This page features the latest news about the UnitedHealth Group stock. FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down Investing.com -- Shares of CVS Health Corp (NYSE ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged ... and other conditions and procedures, the FTC said. The report demonstrates how pharmacy benefit ...

and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector.